Public Release: 22-Feb-2018
Scientists find molecular link between Vitamin A derivative and mouse intestinal health
HIC1 protein could serve as potential target to protect against intestinal disease
IMAGE: ILC3-intrinsic HIC1 is required for immunity to Citrobacter rodentium infection. view more
Credit: Burrows K, et al. (2018)
New research shows that all-trans-retinoic acid (atRA), the active form of vitamin A, regulates immune system responses in the mouse intestine by controlling expression of the protein HIC1 in cells known as innate lymphoid cells. These findings, which could suggest new ways to fight disease, are presented in PLOS Pathogens by Dr Kyle Burrows of the University of British Columbia, Canada, and colleagues.
The intestinal immune system must strike a balance between fighting infection and maintaining tolerance to harmless or beneficial microbes and food particles. Previous research has shown that atRA, produced from dietary vitamin A by some intestinal cells, helps maintain this balance in mice by regulating the activity of innate lymphoid cells. However, the molecular details of this process have been unclear.
In the new study, Burrows and colleagues focused on the protein HIC1, or “Hypermethylated in cancer 1,”so named because it was first identified in cancer cells; however, it also helps regulate gene expression in normal cells. The research team had previously shown that atRA influences HIC1 activity and that HIC1 helps maintain intestinal health in mice. Now, they have investigated the molecular details of HIC1’s role.
The researchers deleted the HIC1 gene in certain innate lymphoid cells in the mouse intestine and found that this increased the susceptibility of the mice to infection with the bacterium Citrobacter rodentium. Further investigation revealed that the increased susceptibility was due to a reduction in production by the innate lymphoid cells of IL-22, a protein that plays a key role in the intestinal immune response.
“Vitamin A has been long known to play a central role in the balance between intestinal immune health and disease, but the precise molecular mechanisms of how it affected immune cells was unknown,” says Professor Colby Zaph from the Biomedicine Discovery Institute at Monash University in Melbourne, Australia. “Identifying HIC1 provides a potential target to modulate intestinal inflammation,” said Prof Zaph, who led these studies.
These results suggest that HIC1 helps maintain intestinal health in mice by regulating the activity of innate lymphoid cells, with its own activity regulated by atRA. With further research, these findings could open up new strategies to protect against infection and intestinal imbalance, which can lead to conditions such as food allergy and irritable bowel syndrome.
In your coverage please use this URL to provide access to the freely available article in PLOS Pathogens: http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006869
Citation: Burrows K, Antignano F, Chenery A, Bramhall M, Korinek V, Underhill TM, et al. (2018) HIC1 links retinoic acid signalling to group 3 innate lymphoid cell-dependent regulation of intestinal immunity and homeostasis. PLoS Pathog 14(2): e1006869. https://doi.org/10.1371/journal.ppat.1006869
Funding: Canadian Institutes of Health Research (http://www.cihr.ca), MSH-95368, MOP-89773, MOP-106623. National Health and Medical Research Council (http://www.nhmrc.org.au), APP1104433, APP1104466. veski (http://www.veski.org.au), VESKI-FA14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.